Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Diabetic Nephropathies"" wg kryterium: Temat


Tytuł:
Intestinal Absorption of Nanoparticles to Reduce Oxidative Stress and Vasoconstriction for Treating Diabetic Nephropathy.
Autorzy:
Liu C; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
Pang M; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
Wang Q; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
Yan M; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
Zhou Y; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
Yao H; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, 100 Science Road, Zhengzhou 450001, China.
Du B; School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Henan Province, 100 Science Road, Zhengzhou 450001, China.
Pokaż więcej
Źródło:
ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2024 Mar 11; Vol. 10 (3), pp. 1517-1529. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Experimental*/drug therapy
Diabetes Mellitus, Experimental*/complications
Animals ; Humans ; Reactive Oxygen Species/metabolism ; Caco-2 Cells ; Vasoconstriction ; Oxidative Stress ; Telmisartan/pharmacology ; Telmisartan/therapeutic use ; Intestinal Absorption
Czasopismo naukowe
Tytuł:
Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating the tight junctions of renal tubular epithelial cells.
Autorzy:
Yang T; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Li L; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Heng C; Department of Pharmacy, JingJiang People's Hospital, Jingjiang 214500, China.
Sha P; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Wang Y; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Shen J; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Jiang Z; New drug screening center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Qian S; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Wei C; New drug screening center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Yang H; Department of Pharmacy, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou 213000, China.
Zhu X; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Wang T; Department of Pharmacy, The affiliated hospital of Xuzhou Medical University, Xuzhou 221006, China.
Wu M; New drug screening center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Wang J; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Lu Q; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Yin X; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China. .
Pokaż więcej
Źródło:
Food & function [Food Funct] 2024 Mar 04; Vol. 15 (5), pp. 2628-2644. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/metabolism
Diabetes Mellitus*/metabolism
Mice ; Animals ; Butyric Acid/pharmacology ; Butyric Acid/metabolism ; AMP-Activated Protein Kinases/metabolism ; Tight Junctions/metabolism ; Epithelial Cells/metabolism ; Fibrosis
Czasopismo naukowe
Tytuł:
Removal of Expression of Concern: Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating tight junction of renal tubular epithelial cells.
Autorzy:
Yang T; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Lia L; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Heng C; Department of Pharmacy, JingJiang People's Hospital, Jingjiang 214500, China.
Sha P; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Wang Y; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Shen J; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Jiang Z; New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Qian S; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Wei C; New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Yang H; Department of Pharmacy, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou 213000, China.
Zhu X; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Wang T; Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China.
Wu M; New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China.
Wang J; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Lu Q; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Yin X; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
Pokaż więcej
Źródło:
Food & function [Food Funct] 2024 Mar 04; Vol. 15 (5), pp. 2772. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Published Erratum; Comment
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/metabolism
Diabetes Mellitus*/metabolism
Humans ; Butyric Acid/metabolism ; Tight Junctions/metabolism ; Epithelial Cells/metabolism ; Inflammation/drug therapy ; Inflammation/metabolism
Opinia redakcyjna
Tytuł:
Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study.
Autorzy:
Tricò D; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Fadini GP; Department of Medicine, Division of Metabolic Diseases, University of Padova, Padua, Italy.
Morieri ML; Department of Medicine, Division of Metabolic Diseases, University of Padova, Padua, Italy.
Candido R; Diabetes Center District 4, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
Disoteo OE; Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Frontoni S; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Solini A; Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Pokaż więcej
Corporate Authors:
PIONEERING EXPERIENCE study group
Źródło:
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Mar; Vol. 40 (3), pp. e3782.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Diabetic Nephropathies*/epidemiology
Diabetic Nephropathies*/etiology
Adult ; Male ; Humans ; Prevalence ; Risk Factors ; Kidney ; Glomerular Filtration Rate ; Albuminuria/epidemiology
Czasopismo naukowe
Tytuł:
Integrative ATAC-seq and RNA-seq analysis associated with diabetic nephropathy and identification of novel targets for treatment by dapagliflozin.
Autorzy:
Shen J; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ying L; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu J; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fang Y; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhou W; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qi C; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gu L; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mou S; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yan Y; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tian M; Department of Burn, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ni Z; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Che X; Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Cell biochemistry and function [Cell Biochem Funct] 2024 Mar; Vol. 42 (2), pp. e3943.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/metabolism
Diabetes Mellitus*
Benzhydryl Compounds*
Glucosides*
Mice ; Animals ; Chromatin Immunoprecipitation Sequencing ; RNA-Seq ; Chromatin ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis.
Autorzy:
Zheng R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xu Q; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhong Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhu R; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 300-314. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/prevention & control
Diabetes Mellitus, Type 2*
MicroRNAs*
Cordyceps*
Animals ; Mice ; Reactive Oxygen Species ; Antibodies ; Inflammation ; Luciferases ; Glucose
SCR Organism:
Cordyceps cicadae
Czasopismo naukowe
Tytuł:
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study.
Autorzy:
Ikejiri K; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Suzuki T; Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Muto S; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Takama H; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Yamawaki K; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Miyazawa T; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Urakawa I; Research and Development Division, Kyowa Kirin Co., Ltd, 1-9-2 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Aoki Y; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Otsuki A; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Katsuoka F; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Kinoshita K; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan.; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan.
Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Akizawa T; Division of Nephrology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
Yamamoto M; Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. .; Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi Aoba-ku, Sendai, Miyagi, 980-8573, Japan. .; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan. .
Pokaż więcej
Źródło:
Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Mar; Vol. 28 (3), pp. 225-234. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/genetics
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/genetics
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/genetics
Oleanolic Acid/*analogs & derivatives
Humans ; NF-E2-Related Factor 2/genetics
Czasopismo naukowe
Tytuł:
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes.
Autorzy:
Scurt FG; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Menne J; Department of Nephrology, KRH Hospital Siloah, Klinikum Region Hannover GmbH, Hanover, Germany.
Brandt S; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Bernhardt A; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Mertens PR; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Haller H; Department of Nephrology, Hanover Medical School, Hanover, Germany.
Chatzikyrkou C; Department of Nephrology, Hanover Medical School, Hanover, Germany.; PHV-Dialysis Center Halberstadt, Halberstadt, Germany.
Pokaż więcej
Źródło:
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Mar; Vol. 40 (3), pp. e3753. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/complications
Humans ; Receptors, Tumor Necrosis Factor, Type II ; Endostatins ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Alisol A inhibits the circ_0001831/miR-346/LIN28B pathway to ameliorate high glucose-induced injury of human renal mesangial cells.
Autorzy:
Yue C; Department of Pharmacology, Xingtai Medical College, Xingtai, Hebei, China.
Dai W; Department of Pharmacology, Xingtai Medical College, Xingtai, Hebei, China.
Song X; Department of Pharmacology, Xingtai Medical College, Xingtai, Hebei, China.
Du M; Department of Pharmacology, Xingtai Medical College, Xingtai, Hebei, China.
Qin J; Department of Test, Xingtai Medical College, Xingtai, Hebei, China.
Du J; Department of Pharmacology, Xingtai Medical College, Xingtai, Hebei, China.
Zhang X; Department of Anatomy, Xingtai Medical College, Xingtai, Hebei, China.
Pokaż więcej
Źródło:
Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Mar; Vol. 29 (3), pp. 154-163. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*/genetics
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/prevention & control
MicroRNAs*/genetics
Cholestenones*
Humans ; Animals ; Mice ; Mesangial Cells ; Inflammation ; Fibrosis ; Glucose/toxicity ; Apoptosis ; Cell Proliferation ; RNA-Binding Proteins/genetics
Czasopismo naukowe
Tytuł:
Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease.
Autorzy:
Gan T; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Wang Q; Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Song Y; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Shao M; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zhao Y; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Guo F; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Wei F; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Fan X; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zhang W; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Luo Y; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Chen D; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Wang S; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Qin G; Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: .
Pokaż więcej
Źródło:
Molecular and cellular endocrinology [Mol Cell Endocrinol] 2024 Mar 01; Vol. 582, pp. 112139. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/metabolism
Diabetes Mellitus, Experimental*/metabolism
Ferroptosis*
Mice ; Animals ; Canagliflozin/pharmacology ; Canagliflozin/metabolism ; Epithelial Cells/metabolism ; Lipid Metabolism ; Fatty Acids/metabolism
Czasopismo naukowe
Tytuł:
A clinical study on roxadustat for anemia in diabetic nephropathy: a 8-week study.
Autorzy:
Jiang L; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
Jia R; National Clinical Research Center of Kidney Diseases, Affiliated Jinling Hospital, Medical School, Nanjing University, Nanjing, 210002, China.
Zheng Z; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
Zhang X; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
Xu Y; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
Raj A; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.; Department of Urology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
Sun D; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. .; Department of Internal Medicine and Diagnostics, Xuzhou Medical University, Xuzhou, 221002, China. .; Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, 99 Huaihai West Road, Quanshan District, Xuzhou, 221001, China. .
Pokaż więcej
Źródło:
International urology and nephrology [Int Urol Nephrol] 2024 Mar; Vol. 56 (3), pp. 1093-1101. Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/complications
Diabetic Nephropathies*/drug therapy
Renal Insufficiency, Chronic*/complications
Anemia*/drug therapy
Anemia*/etiology
Diabetes Mellitus*/drug therapy
Humans ; Cohort Studies ; Retrospective Studies ; Iron/therapeutic use ; Glycine/therapeutic use ; Isoquinolines/therapeutic use ; Cholesterol, LDL ; Inflammation/complications ; Hemoglobins/analysis
Czasopismo naukowe
Tytuł:
Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.
Autorzy:
Yang L; Department of Nephrology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Shen Y; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Li W; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.; Center of Community-Based Health Research, Fudan University, Shanghai, China.; Jiangchuan Community Health Service Center, Shanghai, China.
Zha B; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Xu W; Department of Nephrology, Zhejiang Kaihua County Hospital of Chinese Medicine, Zhejiang, China.
Ding H; Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2024 Mar; Vol. 16 (3), pp. e13508. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 2*
Humans ; Myoglobin ; Glomerular Filtration Rate ; Kidney
Czasopismo naukowe
Tytuł:
Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
Autorzy:
Liu T; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhao H; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Wang Y; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Qu P; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Wang Y; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Wu X; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Zhao T; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Yang L; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Mao H; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Peng L; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Zhan Y; Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Li P; China-Japan Friendship Hospital, Institute of Medical Science, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 28; Vol. 15, pp. 1334109. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
HMGB1 Protein*
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/metabolism
Humans ; Biomarkers ; Kidney/metabolism
Czasopismo naukowe
Tytuł:
Utilizing machine learning algorithms to identify biomarkers associated with diabetic nephropathy: A review.
Autorzy:
Dong B; The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China.
Liu X; Binzhou Hospital of Chinese Medicine, Binzhou, Shandong Province, China.
Yu S; The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Feb 23; Vol. 103 (8), pp. e37235.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/genetics
Diabetes Mellitus*
Humans ; Algorithms ; Biomarkers ; Databases, Factual ; Machine Learning
Czasopismo naukowe
Tytuł:
Early choroidal and retinal changes detected by swept-source oct in type 2 diabetes and their association with diabetic kidney disease: a longitudinal prospective study.
Autorzy:
da Silva MO; Retina and Vitreous Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. .; Graduate Program in Endocrinology, Federal University of Rio Grande do Sul, UFRGS, Rua Landel de Moura 550/209, Porto Alegre, RS, 91920-150, Brazil. .
do Carmo Chaves AEC; Retina and Vitreous Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Graduate Program in Endocrinology, Federal University of Rio Grande do Sul, UFRGS, Rua Landel de Moura 550/209, Porto Alegre, RS, 91920-150, Brazil.
Gobbato GC; Retina and Vitreous Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Lutheran University of Brazil Medical School, Porto Alegre, Brazil.
Lavinsky F; Retina and Vitreous Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Medical School, UNISINOS University, Porto Alegre, Brazil.
Lavinsky D; Department of Ophthalmology, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, Brazil.; Retina and Vitreous Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Graduate Program in Endocrinology, Federal University of Rio Grande do Sul, UFRGS, Rua Landel de Moura 550/209, Porto Alegre, RS, 91920-150, Brazil.
Pokaż więcej
Źródło:
BMC ophthalmology [BMC Ophthalmol] 2024 Feb 23; Vol. 24 (1), pp. 85. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/complications
Diabetic Retinopathy*/complications
Diabetic Retinopathy*/diagnosis
Humans ; Prospective Studies ; Tomography, Optical Coherence ; Retinal Vessels/diagnostic imaging ; Fluorescein Angiography ; Retina ; Choroid/blood supply
Czasopismo naukowe
Tytuł:
Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Autorzy:
Zhang X; Department of Nephrology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China.
Zhang J; Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Ren Y; Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Sun R; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Zhai X; Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Feb 22; Vol. 15, pp. 1368481. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/metabolism
Hyperglycemia*/complications
Diabetes Mellitus*/drug therapy
Humans ; Renin-Angiotensin System/physiology ; Hypoglycemic Agents/therapeutic use ; Blood Pressure
Czasopismo naukowe
Tytuł:
GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways.
Autorzy:
Zhang X; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Wang S; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Chong N; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Chen D; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Shu J; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Sun J; Department of Nephrology, Weifang People's Hospital, Weifang, Shandong, China.
Sun Z; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Wang R; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Wang Q; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: .
Xu Y; Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Feb 15; Vol. 128, pp. 111427. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/metabolism
Growth Differentiation Factor 15*/metabolism
Podocytes*/metabolism
Animals ; Rats ; Inflammation/metabolism ; NF-kappa B/metabolism ; Ubiquitins/metabolism ; Ubiquitins/therapeutic use
Czasopismo naukowe
Tytuł:
Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk.
Autorzy:
Lin YB; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
Chang TJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. .; National Taiwan University School of Medicine, Taipei, Taiwan. .
Pokaż więcej
Corporate Authors:
Taiwan Diabetes Registry Study Group
Źródło:
Scientific reports [Sci Rep] 2024 Feb 13; Vol. 14 (1), pp. 3611. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/epidemiology
Diabetic Nephropathies*/etiology
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 1*/epidemiology
Hypertension*/complications
Hypertension*/epidemiology
Humans ; Male ; Female ; Adult ; Infant ; Age of Onset ; Angiotensin-Converting Enzyme Inhibitors ; Angiotensin Receptor Antagonists ; Cross-Sectional Studies ; Puberty
Czasopismo naukowe
Tytuł:
Identification and validation of immune and cuproptosis - related genes for diabetic nephropathy by WGCNA and machine learning.
Autorzy:
Chen Y; Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Liao L; Guangxi Key Laboratory of Immunology and Metabolism for Liver Disease, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wang B; Department of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, China.
Wu Z; Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 08; Vol. 15, pp. 1332279. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/genetics
Follistatin-Related Proteins*
Diabetes Mellitus*
Animals ; Mice ; Machine Learning ; Area Under Curve ; Databases, Factual
Czasopismo naukowe
Tytuł:
Separating the effects of life course adiposity on diabetic nephropathy: a comprehensive multivariable Mendelian randomization study.
Autorzy:
Zhang H; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Q; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Song Y; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang L; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Cai M; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Bao J; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yu Q; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Feb 08; Vol. 15, pp. 1285872. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Pediatric Obesity*/complications
Pediatric Obesity*/epidemiology
Pediatric Obesity*/genetics
Diabetic Nephropathies*/etiology
Diabetic Nephropathies*/genetics
Diabetes Mellitus*
Adult ; Child ; Humans ; Adiposity/genetics ; Obesity, Abdominal ; Genome-Wide Association Study ; Life Change Events ; Mendelian Randomization Analysis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies